Levels of androgens and danazol metabolites in serum during danazol therapy

other OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-14 ⓘ

This study measured serum androgens in thirteen women with endometriosis treated with danazol, finding that danazol metabolites cause cross-reactivity in radioimmunoassays and necessitate purification for precise androgen quantification.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Thirteen women who had endometriosis were treated with danazol (300 to 400 mg/d). Levels of androgens and danazol metabolites in serum and the influences of danazol metabolites on the assays for serum androgen were investigated during danazol therapy. Serum DHEAS significantly increased (P < 0.05), but serum DHEA slightly decreased. Serum T levels, measured by direct assay, were markedly elevated. However, measured after HPLC separation, the T levels in serum were significantly decreased (P < 0.05). There were considerable cross-reactions between danazol metabolites and androgens (T, DHEA, and A) in RIA. Purification of androgens using column chromatography was necessary to measure serum androgens precisely.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Androgens Danazol Endometriosis Adult Androgens Danazol Danazol Dehydroepiandrosterone Dehydroepiandrosterone Endometriosis Endometriosis Female Humans Middle Aged Testosterone Testosterone

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-09-26T06:15:21.694264+00:00
pubmed
last seen: 2026-05-13T22:11:34.315996+00:00
unpaywall
last seen: 2026-05-16T02:00:00.672124+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine